Target intelligence / Profile preview

UDP-N-acetylglucosamine:N-acetylmuramyl-(pentapeptide) transferase (MurG)

Target
MurG
Molecular classification
Enzyme, Glycosyltransferase, Peripheral membrane protein
01

Overview

MurG is an essential glycosyltransferase enzyme found in almost all bacteria, catalyzing the last cytoplasmic step in peptidoglycan biosynthesis. It transfers an N-acetylglucosamine (GlcNAc) moiety from UDP-GlcNAc to Lipid I, forming Lipid II, a crucial precursor for cell wall assembly[1][7][8]. Structurally, MurG consists of two α/β domains and operates as a peripheral membrane protein, associating with cell membrane phospholipids through a hydrophobic patch surrounded by basic residues[2][8]. MurG participates in multiprotein complexes with other cell wall synthesis enzymes (such as MraY, RodA, and penicillin-binding proteins), and its activity is tightly regulated during bacterial growth and division[3][5][6]. Due to its universal and essential role in bacterial physiology, MurG is an attractive target for new antibiotics, with multiple studies exploring potential inhibitor interactions—most notably, flavonoids like quercetin have demonstrated binding and inhibition in simulation and experimental models[4][6]. Blockade of MurG prohibits Lipid II formation, rendering bacteria unable to maintain a functional cell wall, leading to lysis and cell death.

Other names
MurG glycosyltransferasePeptidoglycan glycosyltransferase MurGUDP-GlcNAc transferase MurG
02

Mechanism of action

Inhibition blocks formation of peptidoglycan precursors, leading to impaired cell wall synthesis and bacterial death

03

Biological functions

Peptidoglycan biosynthesisBacterial cell wall formationTransfer of GlcNAc to Lipid I to form Lipid II
04

Disease associations

Infection (central to bacterial viability)
05

Safety considerations

Selectivity for bacterial MurG is crucial to avoid off-target effectsHuman homologs do not exist, but broad-spectrum antibiotics must be monitored for resistance
06

Interacting drugs

Quercetin

2 more in the full profile.

07

Biomarkers

Increased MurG expression or activity as a marker of bacterial growth or cell wall synthesisAltered peptidoglycan precursor levels (e.g., Lipid I/Lipid II ratio)

Beyond the preview

Go deeper on UDP-N-acetylglucosamine:N-acetylmuramyl-(pentapeptide) transferase (MurG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-N-acetylglucosamine:N-acetylmuramyl-(pentapeptide) transferase (MurG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call